170 related articles for article (PubMed ID: 24236648)
1. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
Stratta RJ; Farney AC; Rogers J; Orlando G
Expert Rev Clin Immunol; 2014 Jan; 10(1):117-32. PubMed ID: 24236648
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunosuppression for pancreas transplantation.
Singh RP; Stratta RJ
Curr Opin Organ Transplant; 2008 Feb; 13(1):79-84. PubMed ID: 18660711
[TBL] [Abstract][Full Text] [Related]
3. Trends in immunosuppression after pancreas transplantation: what is in the pipeline?
Kimelman M; Brandacher G
Curr Opin Organ Transplant; 2013 Feb; 18(1):76-82. PubMed ID: 23254700
[TBL] [Abstract][Full Text] [Related]
4. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
OʼLeary JG; Samaniego M; Barrio MC; Potena L; Zeevi A; Djamali A; Cozzi E
Transplantation; 2016 Jan; 100(1):39-53. PubMed ID: 26680372
[TBL] [Abstract][Full Text] [Related]
6. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Chang SH; Russ GR; Chadban SJ; Campbell S; McDonald SP
Nephrology (Carlton); 2008 Apr; 13(2):171-6. PubMed ID: 18275507
[TBL] [Abstract][Full Text] [Related]
7. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
8. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003.
Gruessner AC; Sutherland DE
Clin Transpl; 2003; ():21-51. PubMed ID: 15387096
[TBL] [Abstract][Full Text] [Related]
9. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
[TBL] [Abstract][Full Text] [Related]
10. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
11. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
Gruessner AC; Sutherland DE
Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
[TBL] [Abstract][Full Text] [Related]
12. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000.
Gruessner AC; Sutherland DE
Clin Transpl; 2000; ():45-72. PubMed ID: 11512358
[TBL] [Abstract][Full Text] [Related]
13. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002.
Gruessner AC; Sutherland DE
Clin Transpl; 2002; ():41-77. PubMed ID: 12971436
[TBL] [Abstract][Full Text] [Related]
14. Present state of immunosuppressive therapy in liver transplant recipients.
Wiesner RH; Fung JJ
Liver Transpl; 2011 Nov; 17 Suppl 3():S1-9. PubMed ID: 21850697
[TBL] [Abstract][Full Text] [Related]
15. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
16. Induction and Immunosuppressive Management of Pancreas Transplant Recipients.
Amorese G; Lombardo C; Tudisco A; Iacopi S; Menonna F; Marchetti P; Vistoli F; Boggi U
Curr Pharm Des; 2020; 26(28):3425-3439. PubMed ID: 32351176
[TBL] [Abstract][Full Text] [Related]
17. Steroid-free immunosuppression in organ transplantation.
Luo G; Falta EM; Elster EA
Curr Diab Rep; 2005 Aug; 5(4):305-10. PubMed ID: 16033684
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression for lung transplantation.
Bhorade SM; Stern E
Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
[TBL] [Abstract][Full Text] [Related]
19. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Opelz G; Döhler B;
Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
[TBL] [Abstract][Full Text] [Related]
20. The current state of pancreas transplantation.
Steen DC
AACN Clin Issues; 1999 May; 10(2):164-75. PubMed ID: 10578705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
